CNE1000062X2
CNE1000062X2
SUNSHINE GUOJIAN PHARMACEUTICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 34.15B EUR | 47.59B EUR | 46.71B EUR | 36.74B EUR |
Enterprise Value | 28.84B EUR | 47.31B EUR | 46.43B EUR | 36.55B EUR |
Valuation Multiples | ||||
Trailing P/E | 11.14x | 16.57x | 16.89x | 13.65x |
Forward P/E | 45.9x | -- | -- | -- |
Price to Sales | 7.72x | 12.05x | 12.15x | 9.86x |
Price to Book | 4.02x | 5.6x | 5.42x | 4.35x |
EV/Revenue | 6.52x | 11.98x | 12.08x | 9.81x |
EV/EBITDA | 8.41x | 14.89x | 14.88x | 11.98x |
Price to FCF (P/FCF) | 20.36x | -- | -- | 159.6x |
EV/FCF | 17.19x | -- | -- | 158.76x |
FCF Yield | 4.91% | -0.08% | -0.07% | 0.63% |